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 2 
Abstract: Autophagy is an evolutionary conserved catabolic pathway whose 23 
modulation has been linked to diverse disease states, including age-associated 24 
disorders. Conventional and conditional whole body knockout mouse models of key 25 
autophagy genes display perinatal death and lethal neurotoxicity, respectively, 26 
limiting their applications for in vivo studies. Here, we have developed an inducible 27 
shRNA mouse model targeting Atg5, allowing us to dynamically inhibit autophagy in 28 
vivo, termed Atg5i mice. The lack of brain-associated shRNA expression in this 29 
model circumvents the lethal phenotypes associated with complete autophagy 30 
knockouts. We show that Atg5i mice recapitulate many of the previously described 31 
phenotypes of tissue-specific knockouts. While restoration of autophagy in the liver 32 
rescues hepatomegaly and other pathologies associated with autophagy deficiency, 33 
this coincided with the development of hepatic fibrosis. These results highlight the 34 
need to consider the potential side effects of systemic anti-autophagy therapies. 35 
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Macroautophagy (herein referred to as autophagy) is an evolutionary conserved, bulk 43 
cellular degradation system required to maintain cellular and energy homeostasis. 44 
Through autophagy, cytoplasmic components such as lipids, proteins and entire 45 
organelles are isolated in double-membrane vesicles (autophagosomes) and 46 
subsequently delivered to the lysosome to facilitate degradation and recycling of their 47 
respective constitutive components. Deregulation of autophagic flux, the rate at which 48 
autophagosomes form, fuse with lysosomes, and breakdown constitutive components, 49 
is believed to play a key role in the development of age-associated disorders, 50 
neurodegenerative conditions, and cancer{White:2015bv, Kroemer:2015im, 51 
GarciaPrat:2016bu, Komatsu:2006iq, Takamura:2011kv, Rosenfeldt:2013em, 52 
Menzies:2015hg}.  53 
 54 
Conventional knockout mouse models of essential autophagy genes, such as Atg5 and 55 
Atg7, display perinatal lethal phenotypes within the first day after birth. This 56 
coincides with a period of metabolic stress wherein neonates must adapt and engage 57 
the autophagic machinery to mobilize their own food stores{Kuma:2004hq, 58 
Komatsu:2005jc}. Additionally, conditional whole-body knockout of Atg7 in adult 59 
mice has provided further evidence for the requirement of autophagy to survive acute 60 
metabolic stress. These mice also experience premature death due to neurotoxicity in 61 
metabolically unstressed states{KarsliUzunbas:2014kg}.  62 
 63 
Due to these limitations there has been a reliance on tissue-specific knockouts to 64 
provide insight into the role of basal autophagy in tissue development and 65 
homeostasis{Mizushima:2010hx}. However, in all such classical approaches there is 66 
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a dependence on the complete and irreversible abrogation of key autophagy genes, a 67 
situation not generally associated with the etiology of human disease or therapeutic 68 
modulation of autophagy. These approaches preclude the ability to perform reversal 69 
experiments and restore autophagy as a mechanism to reverse or modulate the disease 70 
state.  71 
 72 
With this in mind, we have generated an inducible Atg5-shRNA mouse model, which 73 
enables us to inhibit and restore Atg5-dependent autophagy in vivo. The model 74 
enables temporal control of Atg5 levels, which can be made ubiquitous or cell type-75 
specific through breeding with appropriate Cre-recombinase expressing strains. 76 
Herein we have chosen to focus on the characterization of systemic Atg5 down-77 
regulation and provide evidence that these mice display key phenotypes analogous to 78 
those described in knockout models (e.g. hepatomegaly, reduced adipose tissue, and 79 
pancreatic degeneration), indicating a high degree of Atg5 knockdown and autophagy 80 
inhibition in these tissues. Importantly we further utilize the system to ascertain how 81 
reversible these pathological states are, and provide evidence that autophagy 82 
inhibition and subsequent restoration may have pathological consequences. 83 
 84 
Results  85 
To investigate the effects that a reduction in autophagy would have on organismal 86 
homeostasis, and the degree to which these effects are reversible, we have developed 87 
a mouse model incorporating a doxycycline (dox)-inducible shRNA system (Fig. 88 
1A){Dow:2012iw, Premsrirut:2011bm}. Using a sensor-based screening 89 
system{Fellmann:2011ee}, we first obtained a panel of shRNAs against Atg5, an 90 
essential component for autophagosome formation, and then selected an shRNA with 91 
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the greatest knockdown in vitro, Atg5_1065 (see Fig. S1, and Methods). Subsequently 92 
mice were generated carrying a single copy of Atg5_1065 under the control of 93 
doxycycline (dox). Briefly, the TRE (Tetracycline-Responsive Element)-regulated 94 
Atg5-shRNA is downstream of the Col1a1 locus and is GFP-linked providing a non-95 
invasive reporter system of activation. Its transcription is driven in mice by rtTA3 in 96 
the presence of dox, of which spatial expression is restricted courtesy of a loxp-stop-97 
loxp (LSL) cassette (this model is termed LSL-Atg5i mice). To generate a second 98 
version of this mouse model, wherein Atg5 can be ubiquitously knocked-down, we 99 
crossed the LSL-Atg5i mouse to a PGK-Cre expressing strain{Lallemand:1998wn}. 100 
This resulted in germ-line excision of the LSL ‘STOP cassette’, which was passed on 101 
to subsequent generations while the PGK-Cre was rapidly bred out (Atg5i mice). 102 
Atg5i mouse embryonic fibroblasts (MEFs) show a reduction in Atg5 levels and the 103 
conversion of soluble LC3-I to membrane bound LC3-II, an Atg5-dependent process, 104 
by western blot analysis upon administration of dox (Fig. 1B).   105 
 106 
Using a tamoxifen-inducible Cre (Cre-ERT2) system, Atg7 was recently knocked out 107 
systemically in adult mice{KarsliUzunbas:2014kg}. To test the extent to which Atg5i 108 
mice recapitulate gross phenotypes of the whole-body somatic Atg7 knockout (KO) 109 
mice, eight-week old Atg5i mice were placed on a dox-containing diet for 6 weeks. 110 
Similar to the systemic Atg7 KO mice, Atg5i mice on dox appear smaller in size with 111 
smaller weight gain in both genders (Fig. 1C). Anatomical inspection revealed, as in 112 
the whole-body somatic Atg7 KO mice and/or Atg5/7 KO mice, a reduction of 113 
fat{Singh:2009bk} and muscle tissues (Fig. 1D and E){Masiero:2009bq}, with the 114 
presence of hepatomegaly{Komatsu:2005jc}, splenomegaly, and seminal vesicle 115 
atrophy (Fig. 1F, G and H){Yoshii:2016gc}.  116 
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 117 
We next validated Atg5 knockdown in tissues from 6-week dox-treated Atg5i mice. 118 
Western blotting displayed a strong reduction in Atg5 levels as well as a reduction in 119 
the conversion of soluble LC3-I to membrane bound LC3-II (Fig. 2A). This was 120 
reflected in immunohistochemistry (IHC) analyses by the accumulation of p62 (also 121 
known as SQSTM1), an autophagy substrate, forming aggregates to various degrees 122 
depending on tissue/cell type (Fig. 2B and Fig. S2). As reported before, the increase 123 
of poly-ubiquitinated proteins was evident particularly in muscle and heart (Fig. 124 
S2B){Kuma:2017fq}. In addition, pathological features of autophagy deficiency were 125 
also reproduced: e.g. in liver, hepatocytes were enlarged with intracellular 126 
proteinaceous aggregates, and in the pancreas, acinar and islet degeneration was noted 127 
in the dox-treated Atg5i mice (Fig. 2C). These results indicate that the single copy 128 
integration of sh-Atg5 in the genome is sufficient for robust down-regulation of Atg5 129 
and, as a result, of autophagy activity in vivo.  130 
 131 
One notable exception, however, was brain tissue, where we failed to detect any 132 
alterations in Atg5 and poly-ubiquitinated protein levels (Fig. 2A and S2B). This is 133 
consistent with the reported inefficient expression of shRNA in the brain using this 134 
system{Dow:2012iw}. Additionally, in contrast to whole body somatic Atg7 KO 135 
mice, which develop lethal neurodegeneration{KarsliUzunbas:2014kg}, Atg5i mice 136 
displayed no evidence of overt neurological or motor phenotypes, and presented with 137 
normal limb clasping reflexes and brain histology when treated with dox for up to 8 138 
months (Fig. S3). Despite this exception, Atg5i mice recapitulate many of the major 139 




To test the resilience of Atg5i mice to survive the perinatal starvation period, sh-143 
Atg5Homozygous mice were crossed with rtTA3heterozygous mice and fed a dox-containing diet 144 
(Fig. 3A). Only resultant offspring inheriting both components of the system are able 145 
to induce sh-Atg5 expression. Consistent with embryonic Atg5 KO mice, Atg5i mice 146 
were born at close to expected Mendelian ratios (Observed 40%; Expected 147 
50%){Kuma:2004hq}. However, unlike Atg5 KO mice, all embryonic Atg5i mice 148 
were able to survive the neonatal starvation period. Similar results were recently 149 
described wherein restoration of Atg5 expression, ectopically driven from a rat 150 
neuron-specific enolase promoter (NSE), was sufficient to rescue neonatal lethality of 151 
conventional Atg5 KO mice, suggesting that the neonatal lethality of embryonic Atg5 152 
KO mice is primarily due to neurological dysfunction including a suckling 153 
defect{Kuma:2004hq, Yoshii:2016gc}. Although it is formally possible that this lack 154 
of neonatal death phenotype in the Atg5i model is due to hypomorphism of autophagy 155 
deficiency, IHC analyses showed strong accumulation of p62 aggregation in neonatal 156 
liver (Fig. 3B). In addition, and congruent with previous publications, while Atg5i 157 
neonates appeared indistinguishable at birth to their littermate counterparts, their 158 
postnatal development of body size and weight was severely impaired (Fig. 3C-D). 159 
These data reinforce the developmental role of autophagy in neuronal tissues, which 160 
is essential for survival during periods of neonatal metabolic stress{Yoshii:2016gc}. 161 
 162 
Autophagy has a critical role in maintaining energy homeostasis during periods of 163 
starvation-induced stress. Eighty percent of whole-body somatic Atg7 KO mice die 164 
with lethal hypoglycemia during a 24hr fasting period{KarsliUzunbas:2014kg}. To 165 
test whether the Atg5i mice also recapitulate this phenotype, eight-week old Atg5i 166 
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mice were treated with dox for a period of two-weeks and then fasted for 24 hours 167 
with free access to water, to replicate the same experimental design as previously 168 
reported{KarsliUzunbas:2014kg}. At this time point, diminished expression of Atg5 169 
in comparison to control mice was associated with p62 aggregation in the liver (Fig. 170 
4A and B). Unlike whole-body somatic Atg7 KO mice{KarsliUzunbas:2014kg}, 171 
Atg5i mice displayed no evidence of fasting-induced death (Fig. 4C) and maintained 172 
blood glucose levels similar to that of control mice, despite continued suppression of 173 
Atg5 at least in the liver (Fig. 4D). These results indicate that both embryonic and 174 
somatic Atg5i mice are highly robust under metabolic stress conditions, although it 175 
remains to be elucidated whether or not the unaltered autophagy activity in the brain 176 
of Atg5i mice is also responsible for rescuing starvation-induced death in the somatic 177 
model. Furthermore, these results reinforce the unique nature of the Atg5i model, 178 
which provides an opportunity for longer-term experiments involving autophagy 179 
defective adults.  180 
 181 
Next, we examined the effects of restoring autophagy in the Atg5i mice by taking 182 
advantage of the regulatable nature of the system. As in Fig. 2, 8-week old Atg5i and 183 
control mice were fed a dox-infused diet for 6-weeks to induce whole-body Atg5 184 
deficiency. At this point, mice were then switched to a standard diet (absent from 185 
dox) for a further 6 weeks. Within this time window at least, the extent to which the 186 
Atg5 knockdown-associated phenotypes recover upon Atg5 restoration varied 187 
depending on the tissue type (Fig. S4 and S5). Strikingly, during necropsy, livers from 188 
these Atg5-restored mice were found to display no evidence of hepatomegaly (Fig. 189 
5A). The complete reversibility of hepatomegaly was confirmed through a time-190 
course analysis using MRI imaging (Fig. 5B, C and S5B). Re-expression of Atg5 was 191 
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confirmed at the protein level by western blot analysis and was associated with a 192 
normalization of LC3 levels (Fig. 5D), suggesting that autophagic flux had been re-193 
established. 194 
 195 
Additionally, the histopathological alterations associated with autophagy deficiency, 196 
such as swollen hepatocytes and increased proliferation and 197 
apoptosis{Takamura:2011kv}, were absent in the Atg5 reconstituted livers (Fig. 6A 198 
and Fig. S6A and B). Evidence of liver damage and impaired liver function in Atg5i 199 
mice 6 weeks on dox, as measured by elevated serum alanine aminotransferase (ALT) 200 
and reduced serum albumin levels, also reverted to control levels upon dox 201 
withdrawal (Fig. S6C and D).  202 
 203 
Interestingly, we found that autophagy restoration in the liver was also associated 204 
with the induction of hepatic fibrosis as determine by picrosirius red (Fig. 6B and C).  205 
This effect was not seen in Atg5i mice fed dox continuously for 6 or 12 weeks, 206 
suggesting that the increased fibrosis is not an outcome of autophagy deficiency per 207 
se but likely to be a secondary effect of autophagy restoration. This phenotype was 208 
also recapitulated in a short-term setting, where autophagy was restored after dox 209 
addition for 3 weeks (around which point hepatomegaly became evident as shown in 210 
Fig. 5C), although the induction of fibrosis following 3 weeks off dox was modest, 211 
showing only a 2.5-fold increase in collagen staining (Fig. S7), in comparison to a 212 
6.96-fold increase in the 6-week on/off regimen (Fig. 6C). We next stained for α-213 
SMA, a marker of activated hepatic stellate cells (HSCs), mediators of liver fibrosis, 214 
and found a substantial increase of α-SMA after 6-weeks on dox in Atg5i mouse 215 
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livers (Fig. 6D and E). However, consistent with the picrosirius red staining (Fig. 6C), 216 
Col1a1, a major component of liver fibrosis, did not show any increase in these same 217 
livers, but was instead upregulated only after autophagy restoration (Fig. 6B-D). Note 218 
the major source of Col1a1 in the liver is activated HSCs, thus our data suggest that 219 
while HSCs can be activated in the absence of autophagy, they are not fibrogenic. 220 
Interestingly, it has been shown that inhibition of autophagy, either genetically or 221 
pharmacologically, in HSCs can prevent Col1a1 expression and fibrosis during liver 222 
injury{HernandezGea:2012hn}{Thoen:2011bh}. Thus, it is possible that in the Atg5i 223 
mice, systemic autophagy deficiency triggers hepatocyte damage, which activates 224 
HSCs, but the activated HSCs are not fully functional and that the restoration of 225 
autophagy enables the primed HSCs to perform their functional roles, including the 226 
deposition of collagen. Thus, although pathological features of autophagy deficiency 227 
in the liver are largely reversible, transient autophagy inhibition may confer 228 
unforeseen adverse effects. 229 
 230 
In the pancreas, the removal of dox was also associated with the re-expression of 231 
Atg5 and near complete normalization of LC3 levels as evidenced by whole tissue 232 
western blot analysis (Fig. 7A). However, while p62 levels were elevated in both 233 
acinar and islet compartments during dox administration in Atg5i mice, only the 234 
acinar cells of the pancreas displayed a normalization of p62 levels upon dox removal 235 
(Fig. 7C). Consistently, while the acinar portion of the pancreas histologically 236 
recovered, the islets still appeared degenerative with areas of vacuolization apparent 237 
(Fig. 7B and C). Thus, the data suggest that, similar to the liver, autophagy 238 
deficiency-associated phenotypes of the pancreatic acinar are also reversible. 239 
However, in contrast to the liver, the pancreas displayed no evidence of fibrosis after 240 
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Atg5 restoration (Fig. 7C). The reason for the observed irreversibility of islet 241 
phenotype is unclear. Of note, the acinar was found to display evidence of increased 242 
proliferation that was not seen in the islets and may reflect the natural abilities of 243 
these cellular populations to recover upon stress (Fig. S8).  244 
 245 
Discussion 246 
Here we report the first temporally-regulatable mouse model of autophagy, enabling 247 
both down-regulation, and subsequent re-expression of endogenous Atg5 in vivo. 248 
Although this model can be both systemic and tissue-specific, in this study, we 249 
focused on the systemic model to evaluate the overall effects of the system. As 250 
previously described with this system{Dow:2012iw}, Atg5i mice exhibited no 251 
apparent Atg5 knockdown in brain. Interestingly, although further detailed analyses 252 
are required to determine the Atg5 knockdown efficiency in entire tissues/cell types, 253 
the lack of Atg5 knockdown in brain has created a unique situation analogous to the 254 
recently developed Atg5-/-;NSE-Atg5 mice. In these mice, Atg5 is ectopically 255 
expressed under a neuron specific promoter in the conventional Atg5 KO 256 
background{Yoshii:2016gc}. In contrast to Atg5-/-;NSE-Atg5 mice, which is an 257 
embryonic system, in Atg5i mice the shRNA can be induced either embryonically or 258 
somatically, the latter is particularly useful to separate developmental phenotypes 259 
from the role of autophagy in tissue homeostasis. Thus, together with its dynamic 260 
nature, the Atg5i mouse model offers unique and complementary resource for 261 
autophagy studies. However, it is important to note any possibility of off-target 262 
effects of the RNAi in this system. While our model exploits a recently developed 263 
inducible shRNA system, wherein the shRNA is expressed in a miR-E cassette to 264 
allow physiological processing and reduced off-target effects{Fellmann:2013ji}, 265 
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currently we only use one targeting sequence. As such it will be important to develop 266 
further RNAi models targeting alternative sequences of Atg5, or other key autophagy 267 
genes, for further validation of newly described phenotypes. 268 
 269 
We report that Atg5i mice appeared refractory to metabolic stress unlike conventional 270 
and conditional autophagy knockout mice. Analogous to the Atg5-/-;NSE-Atg5 model, 271 
dox-treated Atg5i neonates (where dox was administered throughout embryogenesis) 272 
did not display the characteristic rapid perinatal lethality. Moreover, 24 hours food 273 
withdrawal in adult Atg5i mice was not associated with a lethal hypoglycemic 274 
response, in contrast to somatic Atg7 KO mice, which develop extensive brain 275 
damage. Although, in our Atg5i model, it is not possible to study direct effects of 276 
dynamic autophagy modulation in brain, data from this model raise an interesting 277 
question; whether basal autophagy in the adult brain plays a critical role in systemic 278 
metabolic homeostasis under starvation conditions.  279 
 280 
We leveraged the dynamic nature of our system and show a tissue- or cell type-281 
specific difference in the reversibility of any alterations-associated with autophagy 282 
deficiency, at least during the time range tested.  Further studies will be required to 283 
determine the exact source of this heterogeneity and whether longer restoration times 284 
are required for some tissues. Nevertheless, our model showed near compete 285 
reversibility in the liver and pancreatic acinar. Importantly, in the liver, despite the 286 
full reversibility of pathologies derived from Atg5 knockdown, autophagy restoration 287 
enhanced fibrosis. This does not appear to affect liver function (Fig S6C) but may 288 
alter the long-term fate of the tissue microenvironment. Hepatocyte cell death due to 289 
autophagy inhibition has been previously reported to lead to the activation of HSCs 290 
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and drive fibrosis{Ni:2014bu}. It was also shown that Atg5-deficient macrophages 291 
facilitate chemically-induced liver fibrosis through stimulating myofibroblasts (likely 292 
to be activated HSCs{Iwaisako:2014jk} to express fibrogenic 293 
genes){Lodder:2015jk}. In our Atg5i mice, however, despite hepatocyte cell death, 294 
HSC activation and Atg5 knockdown in immune cells/macrophages (Fig. S9), the 295 
livers of Atg5i mice on dox failed to exhibit collagen deposition and fibrosis which 296 
only developed after autophagy restoration (Fig. 6), reinforcing the critical role of 297 
autophagy within activated HSCs for the fibrogenic activity of these 298 
cells{HernandezGea:2012hn}{Thoen:2011bh}.  299 
 300 
In the clinical setting, autophagy-modulating therapies have garnered interest for life- 301 
and health-span modulation, as well as in the field of oncology {Levine:2015ds, 302 
Rubinsztein:2012hm, Kroemer:2015im}. Particularly for the latter, inhibition of 303 
autophagy (considered as cytoprotective program) has generally been suggested for 304 
use in conjunction with standard chemotherapy. As such the temporal modulation of 305 
autophagy is considered a rational goal to achieve clinical benefit. However, regimens 306 
to-date that modulate autophagic flux do not act specifically on the autophagy 307 
machinery. Instead they often target other components of the cellular system to alter 308 
autophagy and as such distinguishing autophagy specific effects is often difficult. Our 309 
data suggest that the systemic Atg5i mice may be utilized to model specific anti-310 
autophagy therapies. Additionally, there is very little understanding of the potential 311 
adverse effects of switching systemically from an autophagy-low state to an 312 
autophagy-high or restored state, which, as highlighted here, may be associated with 313 
further complications. As shorter regimens of autophagy inhibition appear to result in 314 
reduced fibrosis in this system, we speculate that the timing of dosing, as well as the 315 
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degree of autophagy inhibition, may be a critical determinant in the generation of 316 




For Western: Anti-Atg5 (Abcam ab108327, 1/1000), Anti-LC3 (Nanotools Clone 321 
5F10, 1/1000), Anti-βActin (Sigma), Anti-Actin (Santa Cruz I-19, 1/5000), Anti-α 322 
SMA (Abcam ab5694, 1/1000), Anti-Col1a1 (Abcam ab34710, 1/2000), Anti-poly 323 
Ubiquitin (Enzo Clone FK1, 1:5000), Anti-turboGFP (Pierce PA5-22688, 1/2000), 324 
Anti-Rabbit HRP and Anti-Mouse HRP (1/5000)  325 
 326 
For Immunohistochemistry (IHC): Anti-p62 (Enzo, BML-PW9860, 1/750), Anti-327 
Ki67 (Abcam, ab16667, 1/1000), Anti-Cleaved Caspase 3 (Cell Signalling, #9664, 328 
1/200), Anti-α SMA (Abcam ab5694, 1/500), Anti-Col1a1 (Abcam ab34710, 1/1000). 329 
 330 
Western Blot Analysis 331 
Western blot analysis was performed as previously{Young:2009ew}. Cells and 332 
tissues were lysed in laemmli buffer; tissues samples were homogenized with the 333 
Precellys 24 tissue homogenizer in laemmeli buffer. Samples were run on 12.5% or 334 
15% gels and transferred to PVDF membranes (Immobilon, Millipore). The 335 
membrane was blocked for 1hr at room temperature (5% milk solution in TBS-Tween 336 
0.1%) before incubating with primary antibody at 4oC overnight. Subsequently an 337 
appropriate HRP-conjugated secondary antibody was incubated at room temperature 338 
for 1hr. Western blots were visualized with chemiluminsence reagents (Sigma, 339 




Formalin-fixed paraffin-embedded samples were de-waxed and rehydrated before 343 
antigen unmasking with citrate buffer (pH 6) in a pressure cooker for 5 minutes at 344 
120oC.  Remaining steps were according to the Dako Envision+ Rabbit kit 345 
instructions. 346 
 347 
Picrosirius Red Staining and Quantification 348 
Briefly FFPE slides were de-waxed and rehydrated before being stained with Weigers 349 
Haematoxylin (8 mins), washed in running water (10 mins), immersed in picrosirius 350 
red solution (1hr; Sigma) and washed in acidified water (0.5% acetic acid) for 2 351 
changes. Slides were then dehydrated and cover slipped. Once stained images were 352 
taken at random using a Nikon T-2000 inverted microscope and DSFi-1 camera. The 353 
specimen was illuminated with circularly polarized light by setting the de Senarmont 354 
compensator of the Nikon microscope with the polarizer at 45 degrees to the fast/slow 355 
axes of the quarter-wave plate. A circular polarizer was placed in the light path from 356 
the objective lens, producing a dark field as its circular polarization was opposite to 357 
that of the illuminating beam.  In this condition, the birefringent specimen is 358 
essentially placed between crossed circular polarizers and remains bright at all 359 
azimuthal positions. If an area was found to overlap with a large vessel it was 360 
discounted and images not taken for analysis, in all conditions at least 10 images were 361 
used for analysis. Subsequently, images were analyzed in Fiji by generating a 362 
threshold in a control sample and using this across all samples. The remaining area 363 
count provided ‘positive fibrotic area’. Each sample was then normalized to the mean 364 
value of all the controls.   365 
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 366 
Blood Glucose Homeostasis During Starvation 367 
Blood glucose measurements were taken prior to, and after 24 hours of, food 368 
withdrawal using the ACCU-CHEK Aviva blood glucose monitor. As doxycycline is 369 
provided in the diet of mice, mice also received doxycycline IP (20ml/kg of a 4mg/ml 370 
solution) to ensure continued expression of Atg5_1065.   371 
 372 
Ki67 Counting 373 
For livers, automated counting of Ki-67 across the entire liver section was performed 374 
using ImageScopeTM (Leica Biosystems) customized for the liver and reported as a 375 
percentage of nuclei that stained positively. For the pancreas acinar and islets were 376 
counted separately using HALOTM software (Indicalab) and reported as a percentage 377 
of nuclei that stained positively.  378 
 379 
Cleaved Caspase 3 Analysis 380 
For livers, automated counting of stain positivity across the entire liver section was 381 
performed using ImageScopeTM (Leica Biosystems) customized for the liver and 382 
reported as a percentage of pixels in the image that stained positively, known as a 383 
positive pixel count. 384 
 385 
Islet Degeneration 386 
Each pancreas had all islets available in the histological section imaged and counted 387 
for the presence or absence of islet degeneration. The number of degenerative islets 388 
was calculated as a percentage of the total number of islets visible on one section 389 
 17 
from a single mouse. This was calculated for control and Atg5i mice and a mean and 390 
standard deviation was calculated for each group and displayed graphically.   391 
 392 
MRI 393 
MRI scans were acquired on a 9.4T Agilent MRI scanner running VnmrJ 3.1A and 394 
equipped with gradients of maximum strength 40 G/cm and inner diameter 120mm. A 395 
quadrature millipede coil of inner diameter 40mm was used for all imaging studies. 396 
Coronal fast spin-echo images were acquired with and without fat suppression 397 
employing a chemical-shift-selective sinc-profile RF pulse. Slice thickness was 1mm, 398 
field of view 100mm x 50mm, 512x256 points providing in-plane resolution of 399 
200µm. Up to 18 slices were acquired to cover the full body of the mouse. The 400 
effective echo time was 44ms, echo train length 8, and four averages were acquired to 401 
improve SNR in the liver, which is hypointense with these parameters. Nominal TR 402 
was 3 seconds, but in practice this was determined by the respiratory gating employed 403 
to minimise motion artifacts in the upper abdomen. This sequence gives good contrast 404 
between different soft tissues. Organ volumes were measured by drawing ROIs on the 405 
fat-suppressed images. Fat volume was assessed by subtracting the unsuppressed 406 
images from the suppressed images and thresholding the resulting image. 407 
 408 
Generation and Maintenance of Atg5i Mice 409 
A panel of shRNAs in a Mir-E design{Fellmann:2013ji} targeting Atg5 was obtained 410 
from Mirimus Inc. through a sensor-based screening system {Fellmann:2011ee} in a 411 
pLPE backbone and was used to generate retroviral supernatant. We tested 412 
knockdown efficiency of those shRNAs in NIH3T3 cells and an shRNA showing the 413 
strongest knockdown even with the highest dilution (1% v/v) of viral supernatant was 414 
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taken forward for mouse generation in collaboration with Mirimus Inc (Fig. S1). The 415 
shRNA (Atg5_1065; Guide sequence: TATGAAGAAAGTTATCTGGGTA) was 416 
inserted downstream of the Col1a1 locus via recombinase-mediated cassette exchange 417 
which enables efficient targeting of a transgene to a specific genomic site 500bp 418 
downstream of the 3’ UTR in D34 ES cells expressing CAGS-rtTA3 knocked into the 419 
Rosa26 locus{Beard:2006hz}{Dow:2014be} (Fig. S1C). Mice were maintained on a 420 
mixed C57Bl/6 X 129 background and littermate controls were used in all 421 
experiments. All experimental mice were maintained as heterozygous for both the 422 
Atg5_1065 and CAGS-rtTA3 alleles, while control littermates were absent for one of 423 
the alleles. Mice were maintained in a specific pathogen-free environment under a 424 
12 hr light/dark cycle, having free access to food and water unless otherwise stated. 425 
Mice were fed either a laboratory diet (PicoLab Mouse Diet 20; 5R58) or the same 426 
diet containing doxycycline at 200PPM (PicoLab Mouse Diet; 5A5X). All 427 
experiments were performed in accordance with national and institutional guidelines, 428 
and the study was approved by the ethical review committee of the University of 429 
Cambridge. Imaging of neonates for tGFP expression was conducted using excitation 430 
lamp (460-494nm) and emission filter (500-515nm) (BLS, FHS/LS-1B) optimized for 431 
fluorescent proteins in the green wavelength. 432 
 433 
Liver Immune Cell Isolation: Dissected livers were homogenized (Miltenyi Liver 434 
Dissociation Kit) and passed through a 70μm filter. After centrifugation, red blood 435 
cells were lysed with RBC Lysis Buffer (eBioscience) for 10 minutes. After 436 
centrifugation samples were washed twice in PEB buffer (PBS, EDTA 5μM, BSA 437 
0.5%). Immune cells were initially isolated using an Optiprep gradient (Sigma) and 438 
the F4/80+ population isolated by incubating the immune cell population with F4/80 439 
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MicroBeads (Miltenyi) and passing the mixture through two MACs columns 440 
(Miltenyi) sequentially. Macrophages purified by MACS were stained with Fixable 441 
Viability Dye eFluorTM 780 (Thermo Fisher Scientific) to distinguish live cells from 442 
dead cells.  Subsequently, cells were blocked with TruStain fcX™ (anti-mouse 443 
CD16/32) antibodies (Biolegend) and then stained with fluorchrome-conjugated 444 
antibodies against CD45 (clone 30-F11, Biolegend) and F4/80 (clone BM8, 445 
Biolegend).  Stained cells were analyzed using FACS LSR II (BD) and acquired 446 
results were analyzed by the use of FlowJo software (v10.4, FlowJo, LLC).  447 
 448 
RNA Analysis:  RNA was isolated using Qiagen RNEasy Micro Kit and cDNA 449 
generated using Superscript™ III Reverse Transcriptase (Invitrogen) and random 450 
hexamers. Primer sequences as follows:  451 
Atg5:  Forward 5’-GCCGAACCCTTTGCTCAATG-3’ 452 
 Reverse 5’-TGGTCACCTTAGGAAATACCCAC-3’ 453 
β-Actin: Forward 5’-CAAGAGAGGTATCCTGACCCTGAAG-3’ 454 
    Reverse 5’-CATTGTAGAAGGTGTGGTGCCAG-3’ 455 
 456 
Disclosure of Interest 457 
The authors report no conflict of interest.  458 
 459 
Acknowledgements 460 
We thank G. Hannon, M. Hoare as well as members of the Narita group for their 461 
thoughtful insights and suggestions. We are grateful to the following CRUK 462 
Cambridge Institute core facilities for advice and assistance: Histopathology (B. 463 
Wilson, J. Miller, L.-A. McDuffus for immunohistochemistry and image analysis), 464 
 20 
Light Microscopy (S. Reichelt, J. Pike, L. Berry for Picrosirius imaging and analysis), 465 
and BRU (M. Clayton and H. Jones for animal husbandry).  466 
 467 
Funding 468 
This work was supported by the University of Cambridge, Cancer Research UK and 469 
Hutchison Whampoa. The M.N. laboratory is supported by Cancer Research UK 470 
Cambridge Institute Core Grant (C14303/A17197). This work was also supported by 471 
Wellcome Trust Principal Research Fellowship to D.C.R. (095317/Z/11/Z) and a 472 
Wellcome Trust Strategic Grant to Cambridge Institute for Medical Research 473 
(100140/Z/12/Z). A.J. is supported by a Cambridge Cancer Centre Clinical PhD 474 
research fellowship. M.d.l.R is supported by a Sir Henry Dale Fellowship 475 
(107609/Z/15/Z). M.N. is also supported by a CRUK Early Detection Pump Priming 476 
Award (C20/A20976) and the Medical Research Council (MR/M013049/1).  477 
 478 
Contributions 479 
L.D.C. and M.N. designed the experiments and wrote the manuscript. A.R.J.Y and 480 
P.A.P-M. generated the mouse model. L.D.C and A.R.J.Y performed all experiments 481 
except for shRNA screening in vitro (performed by P.A.P-M.) brain isolation, fixation 482 
and histopathology analysis (performed by B.N., T.R., R.J.G., D.R) and MRI capture 483 
(D.J.O.M). Macrophage isolation was performed by L.D.C, H-C.C. and M.D.L.R. H-484 
C.C performed flow cytometry on enriched samples. A.J. and S.P. analyzed seminal 485 
vesicles. A.J and A.R.J.Y performed RNA isolation and qPCR on isolated immune 486 
cells. All additional tissue histopathology was analyzed blinded by a trained 487 




  491 
 22 
References 492 
{papers2_bibliography}  493 
  494 
 23 
Figure Legends 495 
Figure 1. Generation of Atg5i Mice 496 
(A) Graphical illustration of doxycycline (dox) inducible Atg5-RNAi (Atg5i) system. 497 
Only through crossing with the appropriate Cre-expressing strain is the loxP-STOP-498 
loxP (LSL) cassette excised and rtTA3 protein produced. In the presence of dox, 499 
rtTA3 is able to bind to the tet-responsive element (TRE) and drive the expression of 500 
Atg5-shRNA in a Mir-E backbone. (B) Western blots for indicated proteins in MEFs 501 
isolated from Atg5i mice and littermate control in the presence or absence of dox (3 502 
days). Control littermates lack either the rtTA or sh-Atg5 cassette. (C-G) Eight-week 503 
old Atg5i mice fed on a dox containing diet for 6-weeks display a decrease in weight 504 
(Males, P=0.0017 n=16 control and Atg5i; Females, P=0.0239 n=16 control and 9 505 
Atg5i mice) in C, reduction in inguinal fat weight (P=0.0286, n=4 males per 506 
condition) in D, reduction in muscle weight (P=0.0286, n=4 males per condition) in 507 
E, hepatomegaly (P=0.0006, n=7; 3 females and 4 males per condition) in F, 508 
splenomegaly (P=0.0286 n=4 males per condition) in G, and seminal vesicle atrophy 509 
in H (P=0.0022 n=6 males per condition). All pairwise comparisons determined using 510 
Mann-Whitney test (*P<0.05, **P<0.01 and ***P<0.001). Error bars represent s.d. 511 
around the means.  512 
 513 
Figure 2. In vivo validation of autophagy inhibition upon Atg5 down-regulation 514 
(A) Atg5 shows a down-regulation across a range of tissues in adult mice treated with 515 
dox for 6-weeks by western blot, except the brain, which displays no alterations in 516 
Atg5 in whole tissue extracts. β-Actin serves as a loading control in all tissues except 517 
for heart and muscle for which total Actin was used instead. (B) Atg5i mice display 518 
an increase in p62 in the indicated tissues via IHC. (C) Atg5 down-regulation is 519 
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associated with the development of large proteinaceous aggregates in the liver (yellow 520 
arrows). Additionally, cellular degeneration of the exocrine and endocrine pancreas is 521 
visible by H&E analysis (yellow asterisk). Scale bars= 100μm in B and C. 522 
 523 
Figure 3. Perinatal survival of Atg5i neonates 524 
(A) Breeding strategy for the generation of Atg5i neonates. A doxcycline containing 525 
diet was fed to the parents who each have one component of the two-component 526 
system, thus are unable to induce Atg5-shRNA. Any embryos with both components 527 
however will induce the system. Cont, control. (B) IHC analysis of 14-day-old 528 
neonates highlights the presence of p62 aggregates in the livers of Atg5i mice in 529 
comparison to control. Scale bars= 100μm. (C) Atg5i neonates are born at, and 530 
survive at, expected mendelian ratios. They appear indistinguishable from their 531 
littermate controls except for their positivity for tGFP (bottom). (D) While initially 532 
indistinguishable, Atg5i do not show the same growth kinetics (n= 6 males in both 533 
conditions).  534 
 535 
Figure 4. Adult Atg5i mice survive starvation-induced stress and maintain 536 
glucose homeostasis 537 
(A) Atg5i mice administered dox for 2 weeks and food withdrawal for 24 hours prior 538 
to sacrifice display down-regulation of Atg5 and a reduction of LC3-I to LC3-II 539 
conversion in the liver. (B) These same livers also show the formation of p62 540 
aggregates as seen through immunohistochemical analysis. Scale bars = 100μm. (C) 541 
These mice show no evidence of starvation induced mortality when food is removed 542 
for 24 hours (Control n=6, Atg5i n=4). (D) Blood glucose levels before and after food 543 
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withdrawal show no significant difference between control and experimental (free 544 
feeding P=0.66; Starved P=0.37, Mann Whitney). N.S., not significant. 545 
 546 
Figure 5. Restoration of Atg5 is associated with reversal of hepatomegaly 547 
(A) Consistent with the results in Figure 1F, adult mice treated with dox for 6-weeks 548 
develop hepatomegaly in comparison to control mice (P= 0.0035). However, the 549 
restoration of Atg5 levels in Atg5i mice is associated with a significant reduction in 550 
liver size (P=0.007) to a weight similar to control mice on the same feeding regime. 551 
(n= 8-10 mice per group; Kruskal-Wallis with Dunn’s post test, **P<0.01, N.S., not 552 
significant) (B) Example images of an MRI scan from Atg5i mice at the 6-week on 553 
dox time point, as well as the 6-week on dox -> 6-week off dox time point displaying 554 
hepatomegaly and reversal to normal size, respectively. Yellow dotted lines encircle 555 
livers. (C) Time series analyses of liver size after dox addition, followed by dox 556 
withdrawal using MRI (n=2 mice per condition, average value is shown; see Figure 557 
S5B for individual data).  (D) Adult Atg5i fed on a dox-containing diet for 6-weeks 558 
display a down-regulation of Atg5 and an increase in LC3-I by western blot analysis. 559 
When switched back to a normal diet for 6-weeks mice show a recovery in Atg5 560 
levels and LC3-I, similar to control mice. 561 
   562 
Figure 6. Restoration of Atg5 is associated with the induction of hepatic fibrosis 563 
(A) Representative histology and IHC from the livers of control and Atg5i mice. 564 
Yellow arrows highlight large intracellular inclusions only found in Atg5i mice on 565 
dox. Scale bars= 100μm. (B) Representative images of Picrosirius Red staining in 566 
sections of control and Atg5i mice in the indicated conditions. Scale bars= 100μm. 567 
(C) Only Atg5i mice treated with dox for 6-weeks and off dox for 6-weeks showed 568 
the presence of fibrosis (P=0.0468 Welch’s t-test, error bars represent s.d. around the 569 
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means). **P<0.01; N.S., not significant. (D) Immunohistochemical analysis of livers 570 
from each time point highlights that α-SMA positive activated stellate cells are only 571 
present during the 6-week on dox time point, with Col1a1 staining positivity only 572 
present in the 6-week on dox->6-week off dox time point. (E) Whole tissue protein 573 
extracts display a similar trend with Col1a1 present only in the Atg5i mice at the 6-574 
week on dox -> 6-week off dox time point. 575 
 576 
Fig 7. Atg5 restoration in the pancreas leads to partial phenotypic rescue 577 
(A) Adult Atg5i fed on a dox-containing diet for 6-weeks display a down-regulation 578 
of Atg5 and an increase in LC3-I by western blot analysis. When returned to a normal 579 
diet for 6-weeks mice show a recovery in Atg5 and LC3-I levels, similar to those seen 580 
in control mice. (B) Dox treated adult mice display evidence of islet degeneration that 581 
is not reversed upon dox withdrawal. Mann-Whitney test, ***P<0.001. (C) 582 
Representative histology, IHC, and picrosirius red staining (marker of fibrosis) from 583 
the pancreas of control and Atg5i mice. While p62 levels are increased in both the 584 
islets and acinar of Atg5i mice on dox, only the acinar display a reversal once dox is 585 
removed. Islets do not show a reversal of the degeneration phenotype as viewed by 586 
H&E. Scale bars= 100μm. 587 
 588 
Figure S1. In vitro screening for potent shRNA targeting Atg5 589 
(A) A panel of shRNAs was obtained from Mirimus Inc. in a pLPE backbone. 590 
Retrovirus for each shRNA was generated and knockdown efficiency tested in 591 
NIH3T3 cells. shAtg5#1 (Atg5_1065) provided the greatest knockdown efficiency by 592 
western blot analysis during infection. (B) This occurs at the lowest dilutions of 593 
retrovirus tested with a near complete abrogation of LC3-II conversion. Dilutions are 594 
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shown as percent volume of the retroviral soup directly derived from packaging cell 595 
culture and diluted into the media of NIH3T3. (C) Schematic illustrates the relation 596 
between Col1a1 gene and shRNA cassette. Targeting of the shRNA was achieved 597 
using recombinase-mediated cassette exchange at a specific site 500bp downstream of 598 
the Col1a1 3’UTR in D34 ES Cells{Dow:2014be}{Beard:2006hz}. (D) Homozygous 599 
targeting of the shRNA does not alter Col1a1 expression in MEFs in comparison to 600 
littermate wild-type controls. 601 
 602 
Figure S2. Extended Characterisation of Atg5i Mice 603 
(A) An increase in the staining for the autophagy adaptor protein p62 can be seen in 604 
muscle and heart tissue. Spleen tissue provides a heterogeneous staining even in the 605 
control tissue with an increase in intensity in the Atg5i mice. (B) Western blotting for 606 
poly-ubiqutin highlights an increase particularly in heart and muscle. Brain tissue 607 
shows no alterations. (C) A single gel containing all four tissues (5μg loaded per lane) 608 
highlights the differences in the expression of tGFP, a marker of system activation. As 609 
expected brain tissue displays a much reduced expression due to the bioavailibilty of 610 
dox.  611 
 612 
Figure S3. Atg5i mice display no evidence of neurotoxicity 613 
(A) Adult mice fed on dox-based diet for 6-weeks display normal limb clasping 614 
reflexes in both control and Atg5i cohorts. Note the limbs are extended in both control 615 
and Atg5i mice, unlike limb clasping towards the body as seen in some models of 616 
neurodegeneration (B) Age-matched brain histology from mice treated with dox for 5-617 
6 months (n=3 Atg5i and control mice). Sagittal sections (10 μm) were assessed 618 
blinded across various brain regions with particular emphasis on the cortex and 619 
 28 
hippocampus. Representative images are given for regions spanning cortical layers 620 
and hippocampal pyramidal CA2/3 region layers. Haematoxylin and Eosin (H&E) 621 
staining showed no consistent differences between groups with a staining pattern 622 
reflective of aged mice, such as observable vacuolization. No above baseline TUNEL 623 
positive staining was observed between groups. Scale bars= 20μm. 624 
 625 
Figure S4. Reversibility of phenotype induced by Atg5 knockdown is tissue type 626 
dependent 627 
(A) Inguinal fat weights are significantly reduced in the Atg5i cohorts during dox 628 
administration and do not display a recovery in weight during the 6-week on dox -> 629 
6-week off dox time point. (B) Similarly, splenic weights are significantly different 630 
while on dox, and also do not appear to significantly recover at the 6-week on dox -> 631 
6-week off dox time point. (C) Muscle weight was significantly different between 632 
control and Atg5i mice while on dox, however this significance was lost during the 6-633 
week on dox -> 6-week off dox time point. Mann-Whitney test *P<0.05, **P<0.01, 634 
***P<0.001; N.S., not significant. (D) Time series analyses of total body fat content 635 
after dox addition, followed by dox withdrawal using MRI (n=2 mice per condition, 636 
average value is shown; see Figure S5A for individual data). 637 
 638 
Figure S5. Dynamics of adipose tissue and liver during doxycycline 639 
administration 640 
Individual data points from MRI studies of fat (Fig. S4D) and liver (Fig. 5C) in adult 641 
Atg5i fed on a dox-containing diet for 6-weeks, before being moved to a dox-free diet 642 




Figure S6. Liver functionality reflects Atg5 levels in vivo 646 
(A) Proliferation, as measured through the presence of Ki-67 positive cells in IHC, 647 
was increased after 6-weeks of dox in the Atg5i group in comparison to controls 648 
(P<0.001) and displayed a significant decrease upon Atg5 restoration (P<0.001) to 649 
levels comparable to control mice. One-way ANOVA, n= 5-6 mice per condition. (B) 650 
Apoptosis, as measured by cleaved-caspase 3 (CC3) in IHC, is higher in Atg5i mouse 651 
livers during dox administration compared to control mice (P<0.001). Restoration of 652 
Atg5 is associated with a reduction in CC3 positivity (P<0.001) and a return to basal 653 
levels. One-way ANOVA, n= 3-7 mice per condition. All error bars represent s.d. 654 
around the means. ***P<0.001; N.S, not significant. (C) Serum albumin levels in 655 
Atg5i mice are suppressed in the presence of dox for 6 and 12 weeks in comparison to 656 
controls, P= 0.0460 and P=0.0116 respectively. Serum albumin levels recover to 657 
normal levels once dox is removed from the diet and Atg5 levels are restored. 658 
Kruskal-Wallis Test. n= 4-12 mice per condition with individual values displayed. 659 
(D) Serum ALT levels are significantly increased during a 6-week (P<0.0025, Mann-660 
Whitney) or 12-week period on dox in Atg5i mice (P<0.0001, Mann-Whitney) which 661 
is not present in the 6 weeks on- 6 weeks off dox cohort. *P<0.05, **P<0.01, 662 
***P<0.001; N.S., not significant. 663 
 664 
Figure S7. Short-term inhibition and restoration of Atg5 is also associated with 665 
liver fibrosis 666 
(A) Atg5i mice treated with dox for 3 weeks and subsequently moved to a dox-free 667 
diet for 3 weeks show a similar fibrosis phenotype to the 6-week on dox->6-week off 668 
dox time point. (B) Quantification of sirius red staining at the end of this time course. 669 
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(C-D) Atg5i mice displayed a larger liver after 3 weeks of dox, which reduced in size 670 
to normal levels after dox had been removed as seen by MRI (C) and tissue weight 671 
upon death (D). Values are means of two mice. 672 
 673 
Figure S8. Proliferative index in the pancreas of Atg5i mice 674 
(A) The pancreatic acinar of Atg5i mice displays a higher leveler of proliferation, as 675 
measured through the presence of Ki-67 positive cells in IHC, in comparison to 676 
controls both during dox administration and even after dox was removed from the 677 
diet, although only the 6-weeks on dox and 6-weeks off dox regimen reaches 678 
significance. (B) Conversely, the pancreatic islets did not show an increase in 679 
proliferation. Pairwise comparisons based on Mann-Whitney test. 680 
 681 
Figure S9. Immune cells residing in the liver of Atg5i mice display evidence of 682 
Atg5 knockdown 683 
(A-B) qPCR for Atg5 mRNA (relative to β-actin) in total immune cells and 684 
macrophages (F4/80 positive cells) isolated from the liver of control (Cont) and Atg5i 685 
mice on dox for 6 weeks. (C) Example flow cytometry confirming a high level of 686 
enrichment of F4/80 cells after MACs column enrichment with F4/80 microbeads 687 
(control or Atg5i?). (D) Isolated cells displayed both a high level of viability and a 688 
high level of F4/80 enrichment. 689 
 690 
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